文献速递腹部MR

整合辅助MRI特征对LI-RADS治疗反应算法诊断性能的影响

Incorporation of Ancillary MRI Features Into the LI-RADS Treatment Response Algorithm: Impact on Diagnostic Performance After Locoregional Treatment of Hepatocellular Carcinoma.
PubMed 文献 · AJR Am J Roentgenol · 2021-09-29

该回顾性研究纳入141例HCC局部治疗后行钆塞酸增强MRI并接受肝手术的患者,评估将辅助MRI特征(移行期低信号、肝胆期低信号等)整合到LI-RADS治疗反应算法后对不完全病理坏死诊断性能的影响。随机森林分析确定移行期低信号和肝胆期低信号为显著辅助特征,将其与LR-TR Viable或Equivocal联合可提高敏感度而不降低特异度。

要点

  • 移行期低信号和肝胆期低信号是预测肿瘤存活的显著辅助MRI特征。
  • LR-TR Viable或Equivocal联合移行期低信号可提高敏感度至64.5%,特异度90.9%。
  • LR-TR Viable或Equivocal联合肝胆期低信号可提高敏感度至65.6%,特异度90.8%。

关键影像表现/征象

  • 完全病理坏死见于88/181(48.6%)病灶。
  • 移行期低信号在完全病理坏死、存活肿瘤<10 mm和≥10 mm病灶中的出现率分别为8.0%、25.0%和75.3%。
  • 肝胆期低信号在相应病灶中的出现率分别为9.2%、25.0%和74.0%。

临床应用与阅片要点

  • 阅片时可关注移行期和肝胆期低信号,作为判断肿瘤存活的辅助征象。
  • 对于LR-TR Equivocal的病灶,结合辅助特征可提高检出存活肿瘤的敏感度。

局限性

  • 回顾性单中心研究,样本量有限。
  • 仅纳入接受肝手术的患者,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND. The LI-RADS treatment response algorithm may lack sufficient sensitivity for viable tumor after locoregional treatment (LRT) for hepatocellular carcinoma (HCC). OBJECTIVE. The purpose of our study was to evaluate the impact of incorporation of ancillary MRI features on the diagnostic performance of the LI-RADS treatment response algorithm after LRT for HCC. METHODS. This retrospective study included 141 patients (114 men, 27 women; median age, 56 years) who underwent gadoxetic acid-enhanced MRI after LRT for HCC between October 2005 and January 2020 and subsequent liver surgery. Two readers assessed lesions for LI-RADS features of viability for ancillary MRI features (transitional phase [TP] hypointensity, hepatobiliary phase [HBP] hypointensity, DWI hyperintensity or low ADC, and mild-to-moderate T2 hyperintensity). Interobserver agreement was assessed before reaching consensus. Significant ancillary features were identified using random forest analysis. The impact of incorporation of significant ancillary features on diagnostic performance for incomplete pathologic necrosis (IPN; pathologically viable tumor > 0 mm) was assessed using McNemar tests. RESULTS. Complete pathologic necrosis (CPN) was observed in 88 of 181 (48.6%) lesions. Interreader agreement was almost perfect for LI-RADS features of viability (κ = 0.92-0.97) and was substantial to almost perfect for ancillary features (κ = 0.73-0.94). Random forest analysis identified TP hypointensity (present in 8.0%, 25.0%, and 75.3% of lesions with CPN, viable tumor < 10 mm, and viable tumor ≥ 10 mm, respectively) and HBP hypointensity (9.2%, 25.0%, and 74.0%, respectively) as significant ancillary features. For detecting IPN, LR-TR (treatment response) Viable or LR-TR Equivocal had higher sensitivity than LR-TR Viable (71.0% vs 57.0%, respectively; p = .001) but had lower specificity (86.4% vs 94.3%, p = .02). However, LR-TR Viable or LR-TR Equivocal and TP hypointensity showed higher sensitivity than LR-TR Viable (64.5% vs 57.0%, p = .02) without a significantly different specificity (90.9% vs 94.3%, p = .25). LR-TR Viable or LR-TR Equivocal and HBP hypointensity also showed higher sensitivity than LR-TR Viable (65.6% vs 57.0%, p = .01) without a significantly different specificity (90.8% vs 94.3%, p = .25). CONCLUSION. TP hypointensity and HBP hypointensity increase the sensitivity of LI-RADS treatment response algorithm for viable tumor without lowering specificity. CLINICAL IMPACT. The two identified ancillary features may improve tumor viability assessment and planning of additional therapies after LRT for HCC.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Kim YY, Kim MJ, Yoon JK, et al. Incorporation of Ancillary MRI Features Into the LI-RADS Treatment Response Algorithm: Impact on Diagnostic Performance After Locoregional Treatment of Hepatocellular Carcinoma. AJR Am J Roentgenol. 2021. PMID: 34585608. doi:10.2214/AJR.21.26677

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。